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Abstract
Mobile genetic elements (MGEs) including plasmids and transposons are pivotal in the dissemination and persistence of antimicrobial
resistance in Enterococcus faecalis and Enterococcus faecium. Enterococcal MGEs have also been shown to be able to transfer resistance
determinants to more pathogenic bacteria such as Staphylococcus aureus. Despite their importance, we have a limited knowledge about
the prevalence, distribution and genetic content of speciﬁc MGEs in enterococcal populations. Molecular epidemiological studies of en-
terococcal MGEs have been hampered by the lack of standardized molecular typing methods and relevant genome information. This
review focuses on recent developments in the detection of MGEs and their contribution to the spread of antimicrobial resistance in
clinically relevant enterococci.
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Introduction
Enterococci are important nosocomial pathogens [1]. They
are uniquely armed for the antibiotic era and express intrin-
sic reduced susceptibility to major classes of antimicrobial
agents and biocides [2,3]. The high propensity of enterococci
to acquire and express new resistance determinants further
enhances their ability to sustain antibiotic selection, promot-
ing gastrointestinal colonization and nosocomial infections by
antibiotic-resistant enterococci [4].
Transferable antimicrobial resistance in enterococci was
ﬁrst described in the early 1970s [5–7]. The detection and
molecular clariﬁcation of transferable high-level vancomycin
resistance in Enterococcus faecium in the late 1980s have fur-
ther fuelled our interest in the mechanisms and routes to
antimicrobial resistance in enterococci [8–11]. Importantly,
as residents of human and animal bowel ﬂora, enterococci
are in a position to acquire resistance genes from other
commensals, which may subsequently proceed to other
more pathogenic bacteria [12,13].
Molecular biological studies have elucidated complex func-
tional properties of important mobile genetics elements
(MGEs) involved in transferable resistance in enterococci
[10,14,15]. However, there is a considerable gap in our
knowledge on the molecular epidemiology of MGEs, their
genetic content and composition, as well as their relative
contributions to the spread of deﬁned antimicrobial resis-
tances. Recent progress in molecular typing methods and en-
terococcal genome information has provided new tools and
necessary insights for ﬁlling this gap. This review focuses on
MGEs involved in the spread and expression of clinically
important antimicrobial resistance in enterococci and their
potential contribution to the spread of hospital-adapted clo-
nal lineages of E. faecium and Enterococcus faecalis.
Plasmids as Important Vehicles for Genetic
Information in Enterococci
By deﬁnition, plasmids are semi-autonomously replicating
extrachromosomal genetic elements. Differences in replica-
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tion strategies and modular structures profoundly affect plas-
mid properties, such as size, copy number, host dependence
and host range [16]. The essential backbones for successful
plasmids include genetic modules encoding self-replication,
stable inheritance and the ability to transfer between bacte-
ria. Accessory plasmid content is integrated in between func-
tional plasmid backbone modules and represents a huge
reservoir of genetic variability, often with unknown functions,
that is shared among different bacterial genera through hori-
zontal gene transfer.
There are several criteria to classify plasmids in general
and plasmids related to Gram-postive bacteria in particular.
The mode of replication has been used to distinguish rolling
circle replication plasmids and theta-replicating plasmids. In
addition, plasmids that fail to co-reside in the same cell are
grouped in incompatibility (Inc) groups [17,18]. Inc18 plas-
mids constitute a large group of enterococcal/streptococcal
plasmids with a broad host range [19,20]. Pheromone-
responsive plasmids represent a unique group of self-trans-
ferable (conjugative) narrow host range plasmids mostly
described in E. faecalis [21]. pAD1, pAM373 and pCF10 are
well-known examples of pheromone-responsive plasmids,
where the conjugative process is initiated as a response to
short peptide pheromones produced by pheromone-respon-
sive plasmid-free recipient strains mediating intercellular
aggregation and high-frequency DNA transfer. Recently,
Weaver et al. [22] proposed a new family (RepA_N) of
broadly distributed plasmids in Gram-positive bacteria
encompassing pheromone-responsive plasmids of E. faecalis,
as well as pRUM of E. faecium. Detailed sequence compari-
sons of the replication initiator protein suggest that the repli-
cons have evolved along with their speciﬁc host, explaining
their relatively narrow host range.
Plasmid replicon modules (replicons) have recently been
used as targets of more simplistic methods for typing and
epidemiological tracing of plasmids conferring antimicrobial
resistance (R-plasmids). Other essential gene sets for plasmid
survival, such as mobilization regions, have also been sug-
gested as targets [23]. Given the modular evolution and
genetic plasticity of plasmids, it is of note that schemes based
on different core elements may not be congruent [16]. Ca-
rattoli et al. [18] developed a PCR-based plasmid typing
method based on the replication regions from various plas-
mid incompatibility groups occurring in Enterobacteriaceae.
A similar approach was recently described for the detection
of plasmids from enterococci and other Gram-positive bacte-
ria [24]. On the basis of 111 published sequences from
Gram-positive bacteria, 19 replicon families (rep-family) and
several unique replicons were identiﬁed. Using this PCR-
based typing system, pCF10 (rep9)-, Inc18 (rep1 and rep2)-
and pUSA02 (rep7)-related replicons were identiﬁed as being
most prevalent in E. faecalis strains (n = 28), whereas Inc18
(rep2)-, pRI1 (rep14)- and pRUM (rep17)-related replicons
dominated in E. faecium strains (n = 51) of human and animal
origin [24]. However, approximately 30% of the strains
tested did not support any rep-detection, indicating the pres-
ence of unidentiﬁed rep-types.
The enterococcal-speciﬁc parts of the rep-detection sys-
tem described by Jensen et al. [24] have been used by oth-
ers. A recent study of an epidemiologically diverse collection
of E. faecium strains (n = 93) revealed a high prevalence of
Inc18 (rep2)-, pRUM (rep17)- and pHTb (repunique)-related
replicons [25]. The actual enterococcal typing scheme
accounted for approximately 60% of the total number of
plasmids visualized by S1-nuclease analyses. Interestingly,
strains belonging to hospital-adapted clades (CC17-related)
yielded a signiﬁcant higher number of rep types and pRUM
(rep17)-related replicons in particular, indicating a role in
accessory plasmid DNA for promoting hospital adaptation.
Rep-typing of extended E. faecalis strain collections has so far
shown a dominance of pheromone-responsive plasmid
(rep8 and 9)-, pS86 (rep6)- and Inc18 (rep1 and 2)-related repli-
cons (J. Sun, S. Xiaobo, T. Mikalsen, J. U. Ericson Sollid, A.
Sundsfjord, unpublished observations). Other comprehensive
studies include vancomycin-resistant E. faecium and E. faecalis
strains causing hospital outbreaks in ﬁve continents, from
1986 to date (A. R. Freitas, M. V. Francia, L. Peixe, C. Nov-
ais, L. B. Jensen, R. J. Willems, F. Baquero, T. M. Coque,
unpublished observations). Among E. faecium, mostly CC17-
related, a high diversity of rep types could be identiﬁed; small
[pB82 (rep11), pRI1 (rep14), pEF418 (rep18), pCIZ2 (repunique)]
or medium to large plasmids [Inc18 (rep1 and 2), pRUM
(rep17), pHTb (repunique)], with vanA linked to Inc18- and
pRUM-like plasmids in most cases. Vancomycin-resistant
E. faecalis isolates belonging to major clonal complexes
(CC2, CC9 and CC87) contained a lower diversity of plas-
mids, which were mostly associated with the narrow host
pheromone-responsive pAD1 (rep 9) and Inc18-type (rep1 and
2) plasmids.
Linkage of clinically important resistance determinants to
speciﬁc replicon types in enterococci is of interest for pre-
dicting potential transfer to other bacterial genera by conju-
gative broad host range plasmids. The application of pulsed-
ﬁeld gel electrophoresis of S1-nuclease-digested enterococcal
DNA has proved very useful for the identiﬁcation and sizing
of enterococcal plasmids because they appear as linearized
bands (5–400 kb) on a faint genomic background [25–27].
Physical linkage between deﬁned plasmid rep types and resis-
tance determinants can be visualized by co-hybridization
analysis of linearized plasmid DNAs [25]. Co-hybridization
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analysis and plasmid sequencing have shown linkage of the
vanA operon to Inc18-, pHTbeta- and pRUM-related plasmids
in E. faecium [25,28–31].
Plasmid genomic analysis in enterococci has been hindered
by the comparably high number of extrachromosomal ele-
ments in many (especially clinical) strains; the tremendous
size of several of these plasmids and the multicopy insertion
sequence (IS) elements located on them complicating raw
data and contig assembly. Sequencing of large multiresistance
megaplasmids (>200 kb) are in progress, revealing the pres-
ence of multiple resistance determinants linked to known
virulence-associated proteins (J. A. Laverde-Go´mez, G. Wer-
ner, unpublished observations).
Transposable Elements Involved in Spread
of Resistance in Enterococci
IS elements are the simplest transposable elements encoding
only the enzyme(s) necessary for their own transposition.
Transposons can be classiﬁed into three groups: (i) compos-
ite transposons; (ii) Tn3 family transposons; and (iii) conjuga-
tive transposons [32]. A schematic presentation of
enterococcal transposons from each of these groups is pre-
sented in Fig. 1. An extensive list of transposons containing
speciﬁc resistance and virulence determinants described in
enterococci is given in Table 1.
Composite transposons owe their intracellular mobility to
the presence of ﬂanking copies of IS of the same family that
act together to move the DNA between them and have
mostly been associated with high-level gentamicin resistance
(HLGR) or vanB1-related glycopeptide resistance (Table 1).
The Tn3 family of transposons move (transpose) intracellu-
larly within or between different replicons through a replicative
mechanism promoted by a transposase (TnpA) and a resol-
vase (TnpR) [33]. Tn3-like transposons mediate high-level
glycopeptide (VanA-type) and macrolide-lincosamide-strep-
togramin B (MLSB) resistance in enterococci (Table 1). Con-
jugative transposons (CTns) have been classiﬁed as
integrative conjugative elements (ICE) that encode all infor-
mation necessary for their own excision, conjugation and
integration into a new host [34]. CTns have been associated
with resistance to tetracyclines and MLS-antibiotics as well as
vanB2-related glycopetide resistance (Table 1). Members of
the Tn916/Tn1545-family are considered to comprise classi-
cal conjugative transposons with a broad host range carrying
clinically relevant resistance determinants between a larger
diversity of bacterial genera (Table 1) [35,36]. Importantly,
CTns are also able to co-transfer other plasmids and transpo-
sons, as well as facilitate transfer of large chromosomal frag-
ments between strains [32].
Whole-genome sequencing and comparative genomic anal-
ysis have given insights into the mobile enterococcal DNA
pool [38–40]. The IS appear to represent the major part of
MGEs in clinical enterococcal isolates, and frequently found
IS-families include IS3, IS6, IS30, IS256 and ISL3 [40–57].
Other IS element families found include IS4, IS66, IS110,
IS200/IS605, IS982, IS1182 and IS1380 [40–42,49,51,58–60].
IS16 is prevalent in hospital-adapted subpopulations of E. fae-
cium, but has also been described in clinical E. faecalis strains
and as part of pRUM-like plasmids [40–43].
We have limited knowledge concerning the prevalence
and distribution of deﬁned composite transposons. This is a
result of their highly complex, dynamic and modular struc-
ture, which does not allow simplistic detection and typing
methods. Recently, the ubiquitious presence of Tn916 and
Tn1549/5382-like elements has been demonstrated in oral
and faecal human metagenomes from several countries using
aac6’-
aph2’’
Tn5281 composite transposon
Tn1546 transposon of the Tn3 family
Tn1549-/Tn5382-like conjugative transposon
IS256 IS256
tra region withoriT
1 kb
int xis
tnpA tnpR
vanA cluster 
vanB2 cluster
Transposition module
Resistance module
Intercellular transfer module
Terminal 
inverted
repeats
FIG. 1. Schematic presentation of
transposons from each of the three
transposon groups transferring resistance
genes in enterococci. aac6¢-aph2¢¢,
aminoglycoside-6¢-N-acetyltransferase-2¢¢-O-
phosphoryltrasferase; tnpA, transposase; tnpR,
resolvase; vanA/vanB2 cluster, clusters
conferring vancomycin resistance; tra region,
region containing transfer genes; oriT, origin
of transfer; xis, excisionase; int, integrase.
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TABLE 1. Transposons containing antimicrobial resistance or virulence genes found in enterococci
Tn3 transposon family
Tn designation(s)
Size
(kb)
Replication and
resolvation module Resistance (gene) Host rangea Reference
Tn917 (Tn551)
Tn3871
5,3
5,1
TnpA transposase (tnpA)
and TnpR resolvase (tnpR)
Macrolides, lincosamides
and streptogramin B (ermB)
Bacillus, Enterococcus,
Lactococcus, Listeria,
Paenibacillus, Staphylococcus,
Streptococcus
[157–159]
Tn1546 and variants 11 TnpA transposase (tnpA)
and TnpR resolvase (tnpR)
Glycopeptides (vanA) Enterococcus, Staphylococcus
aureus, Staphylococcus
epidermidis, Bacillus
circulans, Oerskovia turbata,
Arcanobacterium haemolyticum,
Paenibacillus, Rhodococcus
[10,13]
Composite transposons
Tn designation(s) Size (kb)
Flanking
IS elements Resistance (gene) Host rangea Reference
Tn5281 (Tn4001),
Tn3706 and
variants
of these
4,7 Inverted copies of
IS256 or IS257
Aminoglycosides
(aac(6¢)-aph(2¢¢))
Enterococcus, Mycoplasma,
Staphylococcus, Streptococcus
[124,160–165]
Tn924 27 IS257-like Aminoglycoside
(aac(6¢)-aph(2¢¢))
Enterococcus faecalis [166]
Tn1547 64 IS16 and IS256-like in a
direct orientation
Vancomycin (vanB1) Enterococcus faecalis [43]
Tn5384 26 Directly repeated
copies of IS256
Aminoglycosides
(aac(6¢)-aph(2¢¢)),
erythromycin (ermB),
mercuric chloride (merX)
Enterococcus faecalis [167,168]
Tn5385 Ca 65 Directly repeated
copies of IS1216
Aminoglycosides
(aac(6¢)-aph(2¢¢)),
erythromycin (ermB),
mercuric chloride (mer),
streptomycin (aadE),
tetracycline-minocycline
(tetM), penicillin (blaZ)
Enterococcus faecalis [69,169]
Tn5405 and variants 12 Inverted copies
of IS1182
Aminoglycosides (aphA-3,
aadE), streptothricin
(similar to sat4)
Enterococcus faecium,
Staphylococcus
[60,170]
Tn5482 26–30 IS1216V Glycopeptides (vanA) Enterococcus faecium,
Enterococcus faecalis
[44]
Tn5506 39 IS1216V2 in inverted
direction of IS1216V1
with IS1252 insertion
Glycopeptides (vanA) Enterococcus faecium [50]
Conjugative transposons (ICEs)
Tn designation(s) Size (kb)
Recombination
module
Resistance/virulence
(gene) Host rangea Reference
Tn916, Tn918, Tn919,
Tn920, Tn925,
Tn3702, Tn5031,
Tn5032, Tn5033,
Tn5381, Tn5383
15–23 Tn916 tyrosine
recombinase/integrase
(int) and excisionase (xis)
Tetracycline-minocycline
(tetM)
Species within the
following genera:
Acholeplasma, Acinetobacter,
Actinobacillus, Alcaligenes,
Bacillus, Butyrivibrio, Citrobacter,
Clostridium, Enterococcus,
Erysipelothrix, Escherichia,
Fusobacterium, Granulicatella,
Haemophilus, Lactobacillus,
Lactococcus, Leuconostoc,
Listeria, Mycoplasma,
Neisseria, Peptostreptococcus,
Pseudomonas, Staphylococcus,
Streptococcus, Thermus,
Ureaplasma, Veillonella
[171–179]
Tn1545 and variants Ca 25 Tyrosine recombinase/
integrase (int) and
excisionase (xis) related
to those from Tn916
Tetracycline-minocycline
(tetM), macrolides,
lincosamides and
streptogramin B (ermB),
kanamycin (aphA-3)
Species within the following
genera: Bacillus, Bacteroides,
Clostridium, Enterococcus,
Escherichia, Eubacterium,
Lactococcus, Listeria, Neisseria,
Roseburia, Staphylococcus,
Streptococcus, Ureaplasma
[180,181]
Tn6009 18 Tyrosine recombinase/
integrase (int) and
excisionase (xis) related
to those from Tn916
Tetracycline-minocycline
(tetM), mercury (mer)
Enterococcus, Klebsiella,
Pseudomonas, Serratia,
Streptococcus
[182]
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integrase-speciﬁc probes for detection [61,62]. Detection of
the most common CTns associated with tetracycline, macro-
lide or chloramphenicol resistance revealed the wide spread
of sequences related to Tn916/Tn1545, Tn5397, and also
CW459TetM/Tn5801and CTn6000 among enterococci from
different sources (C. Novais A. Freitas, F. Baquero, L. Peixe,
M. Zervos, A. Roberts, T. M. Coque, unpublished observa-
tions), while Tn1549/5382-like elements are the most com-
mon vehicle for dissemination of VanB-type glycopeptide
resistance in enterococci [42,63–66].
Transposable Elements: Contribution to
Genome Plasticity and Phenotypic
Variation
Genomic comparisons of host-adapted and less host-adapted
species suggest a higher prevalence of mobile elements
among the latter, specifying a comparably high genomic sta-
bility in very well host-adapted species and a comparably high
genomic plasticity in variants with changing hosts or
approaching new ecological niches [67]. The latter may be
true for the recently emerging hospital-adapted clonal types
of E. faecium and E. faecalis and may explain their large con-
tent of IS and other mobile elements among their genomes
compared to other representatives, also within the same
species (E. faecalis OG1RF/Symbioﬂor 1) [39,68]. Transpos-
able elements may contribute to genome plasticity by several
mechanisms. Multiple copies of related transposable elements
are substrates for homologous recombination within and
between different DNA elements mediating rearrangements
in chromosomal and plasmid DNA [50,69,70]. Moreover,
transposable elements may alter the expression of genes
either through disruption of genes by insertion within the
coding region or by integrations in the promoter region,
either disrupting the existing promoter or providing a new
and more efﬁcient promoter. Enterococcal ISs found to con-
tribute to the formation of functional promoters include IS3,
IS30, IS256 and IS982 [71]. IS1542 and IS1191, both belong-
ing the IS256 family, have been shown to contribute to con-
stitutive expression of the vanA operon and to a higher level
of bioﬁlm formation in a virulent E. faecalis, respectively
[45,47]. Moreover, the constitutive expression of vancomycin
resistance in vanD isolates can be a result of ISEfa4 (IS200/
IS605 family) insertion in the vanD operon regulator compo-
nent determinant vanSD [59] and IS19 (IS982 family), disrupt-
TABLE 1. (Continued)
Conjugative transposons
Tn designation(s) Size (kb)
Recombination
module
Resistance/virulence
(gene) Host rangea Reference
Tn5382,Tn1549 and
variants of these
27–34 Tyrosine recombinase/
integrase (int) and
excisionase (xis)
related to those
from Tn916
Vancomycin (vanB2) Enterococcus faecium,
Enterococcus faecalis,
Enterococcus gallinarum,
Enterococcus hirae, Clostridium,
Streptococcus, Ruminococcus,
Eggerthella lentha
[42,63,64,104,
105,108,183]
Tn5386 29 Tyrosine recombinase/
integrase (int) and
excisionase (xis)
related to those
from Tn916
Lantibiotics (spa), putative
surface exposed
collagen adhesion protein
Enterococcus faecium [184]
OG1RF conjugative
transposon homologue
Ca 49 Putative phage-
related integrase,
lacks excisionase
homologue
Putative adhesin proteins Enterococcus faecalis [39]
Tn6000/EfcTn1 33 Excisionase and integrase
related to those from
S. aureus pathogenicity
islands SaPIbov and SaPIbov2
Tetracycline (tetS) Enterococcus faecalis,
Enterococcus faecium,
Enterococcus casseliﬂavus,
Enterococcus spp.
[36,185; C. Novais,
A. Freitas, F. Baquero,
L. Peixe, M. Zervos,
A. Roberts, T. M. Coque,
unpublished observations
CW459TetM/Tn5801
(Tn6104)
Ca 25 Integrase not related
to Tn916
Tetracycline-minocycline
(tetM)
Enterococcus faecium,
Enterococcus faecalis,
Enterococcus spp., Staphylococcus
aureus, Clostridium perfringens
C. Novais, A. Freitas,
F. Baquero, L. Peixe,
T. M. Coque, unpublished
observations
V583 vanB1-containing
element
55 TndX-like large serine
recombinase
Vancomycin (vanB1) Enterococcus faecalis [38]
Tn5397 and variants Ca 21 TndX-like large serine
recombinase
Tetracycline-minocycline
(tetM)
Enterococcus faecium,
Enterococcus hirae, Clostridium
difﬁcile, Bacillus subtilis, Streptococcus
[186,187]
Tn950 47 Unknown, not
homologous
with Tn916
Erythromycin Enterococcus faecium [188]
aHost range includes both hosts into which the elements have been introduced and hosts in which they occur naturally.
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ing the ddl gene encoding the housekeeping D-Alanine-D-Ala-
nine ligase. Absence of D,D-carboxypeptidase activity in an
E. faecium strain occurred as a result of ISEfa9 (IS3 family)
insertion in vanYD which contributes to lowering the glyco-
peptide resistance level [49].
MGE and their Contribution to Speciﬁc
Resistance Phenotypes
Transferable resistance to vancomycin
Subsequent to its ﬁrst description [8,9], the vancomycin
resistance operon (van) alphabet has expanded to eight in
enterococci, namely the aquired vanA, vanB, vanD, vanE,
vanG, vanL [72] and vanN [73] in addition to the intrinsic
vanC genotype in E. gallinarum and E. casseliﬂavus. Their
characteristics and species distribution are summarized in
Table 2. The vanA and vanB genotypes are the most com-
monly encountered forms of acquired glycopeptide resis-
tance and have primarily been reported in E. faecium and
E. faecalis. The mechanisms of resistance involve modiﬁca-
tion of the vancomycin-binding target by synthesis of pepti-
doglycan precursors with peptide sidechains that terminate
in D-lactate (vanA, vanB and vanD) or D-serine (vanC, vanE,
vanG, vanL and probably vanN) for which vancomycin has
lower afﬁnity than for the normal D-alanine sidechain termi-
nus [74–77]. Detailed descriptions are provided in recent
reviews [78,79].
The vanA gene cluster is carried by Tn1546, a Tn3 deriva-
tive that is most often found as a part of nonconjugative or
conjugative plasmids [10,44,50,80]. Broad host range Inc18
plasmids have been associated with transfer of Tn1546 from
enterococci to Staphylococcus aureus [81]. The vanB operon
can be transferred between enterococci as part of large con-
jugative chromosomal elements or by conjugative plasmids
[42,43,63,64,82–89]. The vanB ligase gene has been divided
into three subtypes, vanB1-3, based on nucleotide sequence
differences [90–92]. The vanB2 subtype as an integral part of
Tn1549/Tn5382-like conjugative transposons [42,63–66] is
the most widespread vanB type in clinical enterococci
[42,65,80,89,93–100]. Interestingly, the ﬁrst description of a
vanB2-Tn1549-like element in pheromone-responsive
(pCF10-like) plasmids in E. faecalis strains was recently
reported from Japan [89]. The occurrence of vanB1 has only
been described for single isolates as an integral part of puta-
tive ICE or composite transposons [38,43].
A high prevalence of the vanB2 gene has been observed in
community and hospital human faecal specimens in the
TABLE 2. Glycopeptide resistance due to van-type gene clusters
Aquired Intrinsic
Resistance
level
High Variable Moderate Low Low
Type VanA VanB VanD VanE VanG VanL VanN VanC
MIC in mg/L:
Vancomycin
Teicoplanin
‡16
>8
‡4
0,5-1
‡64
4–64
6–32
0,5
12–16
0,5
8 8 2–32
0,5-1
Expression Inducible Inducible Constitutive/
Inducible (vanD2)
Inducible/
(Constitutive)
Inducible Constitutive/
Inducible
van ligase gene vanA vanB1-B3 vanD1-5 vanE vanG1-2 vanL vanN vanC1-C3
Modiﬁed target D-alanine-D-lactate D-alanine-D-lactate D-alanine-D-lactate D-alanine-
D-serine
D-alanine-D-
serine
D-alanine-
D-serine
D-alanine-
D-serine?
D-alanine-
D-serine
Conjugative
transfer
Yes Yes No No Yes No Yes No
Location Plasmid/chromosome
on transposon(s)
Plasmid/chromosome
± transposon/ICEa
Chromosome Chromosome Chromosome on
possible ICE
Chromosome? Plasmid Chromosome
Distribution Enterococcus faecium
Enterococcus faecalis
Enterococcus avium
Enterococcus casseliﬂavus
Enterococcus durans
Enterococcus gallinarum
Enterococcus hirae
Enterococcus mundtii
Enterococcus rafﬁnosus
Staphylococcus aureus
Bacillus circulans
Oerskovia turbata
Arcanobacterium haemolyticum
Paenibacillus
Rhodococcus
Enterococcus faecium
Enterococcus faecalis
Enterococcus casseliﬂavus
Enterococcus durans
Enterococcus gallinarum
Enterococcus hirae
Staphylococcus epidermidis
Streptococcus
Clostridium
Ruminococcus
Eggerthella
Enterococcus faecium
Enterococcus faecalis
Enterococcus avium
Enterococcus gallinarum
Enterococcus rafﬁnosus
Non-enterococcal
faecal ﬂora
Enterococcus
faecalis
Enterococcus faecalis
Non-enterococcal
faecal ﬂora
Enterococcus
faecalis
Enterococcus
faecium
Enterococcus
gallinarum
– vanC1
Enterococcus
casseliﬂavus
– vanC2/3
aICE, integrative conjugative element.
546 Clinical Microbiology and Infection, Volume 16 Number 6, June 2010 CMI
ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 541–554
No claim to original US government works
absence of cultivable vancomycin-resistant enterococci (VRE)
[101–103]. This could be explained by the presence of
vanB2-Tn1549/Tn5382-like elements identiﬁed in other bac-
terial genera belonging to the normal intestinal ﬂora, such as
Clostridium, Ruminococcus, Eggerthella and Streptococcus [104–
106]. The high rates of non-enterococcal vanB in faecal sam-
ples result in a low predictive positive value for VRE using
PCR-detection of vanB directly from faecal samples [103],
whereas detection of vanA is considered highly speciﬁc [107].
These observations are also consistent with the recent
description of Tn1549 integrase in ﬁve of six faecal metage-
nomes from several European countries [62]. Furthermore,
conjugative transfer of vanB2-Tn1549/Tn5382-like elements
from Clostridium symbiosum to enterococci in the gut of gno-
tobiotic mice was recently described during vancomycin
selection [108]. Thus, vanB2 genes are already part of the
normal faecal ﬂora, and treatment with vancomycin might
select for accidental transfer events to relevant human
Gram-positive pathogens including enterococci. Indeed, rates
of infections with vanB-type VRE (mainly E. faecium) are
increasing in several European countries [109]. Most worry-
ing is the ﬁnding of vanA-type vancomycin resistance in meth-
icillin-resistant S. aureus (MRSA): VRSA. A detailed
description of VRSA is provided elsewhere [81]. S. aureus
may coexist with VRE in the gastrointestinal tract or in
superﬁcial wounds, providing a likely reservoir for develop-
ment of VRSA [110]. Most recent outbreaks and clinical
infections with VRE worldwide are a result of genetic lin-
eages of hospital-adapted E. faecium [57,96,100,111–116] that
have aquired several virulence and resistance determinants,
increasing its ability to survive and cause disease in nosoco-
mial environments [117–122].
High-level resistance to aminoglycosides
Acquisition of HLGR abolishes the synergistic bactericidal
effect in combination with cell wall active agents in the treat-
ment of severe enterococcal infections. The HLGR pheno-
type is most commonly associated with the bifunctional
enzyme AAC(6¢)-Ie-APH(2¢¢)-Ia and the APH(2¢¢)-I-family.
The composite transposon Tn5281 (IS256-related) or its
variants have been shown to harbor the aac(6¢)-Ie-aph(2¢¢)
determinant as part of conjugative enterococcal plasmids
[123,124]. pMG1 is a fully sequenced conjugative pHTbeta-
like 65-kb plasmid from E. faecium containing a Tn5281-like
element [31]. pMG1-related replicons have been associated
with transferable VanA-type vancomycin resistance and
HLGR in E. faecium in the USA, Japan, the UK and the Neth-
erlands [125,126]. HLGR in invasive E. faecium and E. faecalis
strains in European countries is increasing [127,128; http://
www.rivm.nl/earss/].
Linezolid resistance
Linezolid is an oxazolidinone antibiotic used in the treatment
of infections caused by multidrug-resistant enterococci.
Resistance, still uncommon in enterococci, is associated with
mutations in central loop domain V of the 23S ribosomal
RNA gene that affect the binding afﬁnity between target and
drug [129]. The ﬁrst mutation in a single 23S allele is the key
event in the development of linezolid resistance. Exchange of
alleles via recombination occurs then readily, leading to a
stepwise increasing resistance level [130]. If not all alleles
have recombined, the resistance genotype is reversible. This
type of acquired resistance is not transferable and spreads
only clonally. Importantly, a new form of linezolid resistance
has recently been described in staphylococci, Cfr, for chl-
oramphenicol-ﬂorfenicol resistance [131]. The cfr determi-
nant was originally described as plasmid-mediated and
encodes a methylase that modiﬁes the 23S rRNA ribosomal
subunit, conferring cross-resistance to linezolid. The ﬁrst cfr
determinant was present in a genetic context including ermB
and it was suggested to be of enterococcal origin. The cfr
determinant has so far not been described in enterococci.
Resistance to quinopristin-dalfopristin (Q/D)
E. faecalis is intrinsically resistant to Q/D as a result of the
presence of the lsa determinant, whose function remains to
be established [132]. Several mechanisms of acquired Q/D
resistance have been described in E. faecium, including 23S
rRNA gene methylation, enzymatic inactivation of streptogr-
amin A and efﬂux pumps [133,134]. Enterococcal plasmids
harbouring vat(D) and vat(E) determinants encoding acetyl-
transferases and determinants for MLSB resistance inactivat-
ing streptogramins A and B have been described [135–137].
Resistance to tigecycline
Only sporadic enterococcal isolates with phenotypic inter-
mediate or borderline resistance (MIC = 0.5/‡1 mg/L) are
reported in larger clinical trials. The molecular basis of tige-
cycline resistance in a single clinical E. faecalis isolate from an
intensive care unit patient after prolonged tigecycline therapy
has been investigated. Tigecycline resistance was stable in
this epidemic, hospital-adapted strain type (ST6/clonal com-
plex CC2). The mechanism of tigecycline resistance was not
clariﬁed [138].
Interactions between transferable antimicrobial resistance
and pathogenicity
Several enterococcal plasmids have been shown to contain
determinants associated with increased capacity for coloniza-
tion and infection. In some instances, resistance genes and
virulence determinants have been physically linked to the
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same plasmid. The pheromone-responsive plasmid pAD1
encodes cytolysin [139] and aggregation substance (AS)
[140]. pCF10 encodes AS [141], and the bacteriocin 21 gene
(bac21) is found on pPD1 [142], bac32 on pTI1 [143], bac41
on pYI14 [144] and bac43 on pDT1 [145]. The bac41 gene
was also recently described as genetically linked to vanB2 on
the pheromone-responsive and highly conjugative plasmid
pMG2200 [89]. AS has been associated with vanA-containing
pheromone-responsive plasmids in E. faecalis [146] and
E. faecium [50,147]. Furthermore, large conjugative hylEfm-
positive plasmids encoding VanA-type vancomycin resistance
and/or resistance to erythromycin and high levels of gentami-
cin were recently found in E. faecium CC17-related strains
[27,37]. These plasmids might also have a role in the success
of the CC17 E. faecium genotype.
Persistence of R plasmids in the absence of antibiotic selec-
tion
Plasmids have systems that ensure stable inheritance. Inter-
estingly, some R-plasmids contain plasmid addiction systems
encoding labile anti-toxins and stabile and potent toxins that
are able to kill daughter cells that do not inherit the plasmid
during cell division (Fig. 2). Thus, once acquired, the R-plas-
mids ensure their own maintenance even in the abscence of
antibiotic selection. Three functional plasmid addiction (TA;
toxin–antitoxin) systems have been identiﬁed in enterococci;
Axe-Txe in pRUM [41], epsilon-zeta in pVEF2 [28,148] and
par/Fst system in pAD1 [149]. A prevalent genetic linkage
between the pRUM-replicon type and axe-txe has recently
been demonstrated in E. faecium strains, suggesting a suc-
cessful plasmid backbone combination [25]. The stability of
vanA-Inc18 plasmids in enterococci in the absence of glyco-
peptide selection has previously been linked to the epsilon-
zeta TA-system [29,150]. The results of competitive ﬁtness
experiments of vanA plasmid-containing vs. recipient E. fae-
cium cells revealed that environmental adaptation, in vivo
gene transfer and plasmid maintenance system(s) favoured
long-term VRE persistence without antibiotic selection and
compensate for the biological costs of possessing the resis-
tance genes [151]. These earlier in vitro experiments accom-
pany recent prevalence studies of VRE among animal
reservoirs in the absence of a direct antibiotic selective pres-
sure [152,153].
New protection mechanisms against foreign DNA – means
to limit the spread of antibiotic resistance?
Clustered, regularly interspaced, short palindromic repeats
(CRISPR) have been shown to provide immunity to foreign
DNA (phages and plasmids) by direct sequence match [154].
Many CRISPR elements contain phage sequences that pro-
vide the host with viral resistance [155,156]. In addition,
sequences homologous to the nickase gene in conjugative
plasmids of methicillin- and vancomycin-resistant S. aureus
(MRSA and VRSA) are also found in functional CRISPR ele-
ments, interfering with plasmid conjugation and transforma-
tion in Staphylococcus epidermidis [156]. By contrast, a BLAST
search of seven fully sequenced E. faecium strains found no
functional CRISPR elements, whereas prophage sequences
were common (Van Schaik, personal communication).
Almost no mobile genetic elements were found in the fully
sequenced E. faecalis OG1RF that contains two CRISPR ele-
ments [39]. An association was noted between the presence
of CRISPR and the absence of prophages in this particular
strain in contrast to V583. The role of CRISPR in the pro-
FIG. 2. Toxin–antitoxin (TA) pairs contribute
efﬁciently to plasmid maintenance in a
bacterial population. If TA-carrying plasmids
are not inherited by the daughter cells after
cell division, the less stable antitoxin is
degraded by proteases and the toxin is left
free to interact with its intracellular target,
which leads to growth inhibition or cell
death.
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tection of foreign DNA in enterococci remains to be exam-
ined.
Concluding Remarks
Recent progress in enterococcal genome information and in
the development of simplistic typing methods has allowed
new insights into the prevalence, distribution and genetic
content of MGEs in enterococci. This may allow an assess-
ment of their relative contributions to the spread of deﬁned
resistance phenotypes and the potential risk for transfer to
other bacterial genera by broad host range conjugative ele-
ments. The identiﬁcation of mechanisms involved in mainte-
nance of R-plasmids has provided information that, at least
in part, can explain the persistence of deﬁned transfer-
able resistances in the absence of antibiotic selection. The
potential use of genetically manipulated CRISPR interference
mechanisms to limit the spread of antibiotic resistant entero-
cocci needs to be examined.
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